These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9777766)

  • 1. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
    Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Guenther LC; Poulin YP; Pariser DM
    Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
    Green L; Sadoff W
    J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
    Lebwohl M
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazarotene in combination with topical corticosteroids.
    Lebwohl M; Poulin Y
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
    Dando TM; Wellington K
    Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing treatment with topical tazarotene.
    Guenther LC
    Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
    Gollnick H; Menter A
    Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
    Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
    Bowman PH; Maloney JE; Koo JY
    J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
    Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
    J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy.
    Tanghetti E; Lebwohl M; Stein Gold L
    J Drugs Dermatol; 2018 Dec; 17(12):1280-1287. PubMed ID: 30586259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene combination treatments in psoriasis.
    Guenther L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
    Angelo JS; Kar BR; Thomas J
    Indian J Dermatol Venereol Leprol; 2007; 73(1):65. PubMed ID: 17319037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
    Krueger GG; Drake LA; Elias PM; Lowe NJ; Guzzo C; Weinstein GD; Lew-Kaya DA; Lue JC; Sefton J; Chandraratna RA
    Arch Dermatol; 1998 Jan; 134(1):57-60. PubMed ID: 9449910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of tazarotene: optimizing clinical results.
    Lebwohl M
    Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of topical tazarotene: a review.
    Talpur R; Cox K; Duvic M
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):195-210. PubMed ID: 20213916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene in combination with phototherapy.
    Koo JY
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.